U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
Cosyntropin (ACTH (1–24)) is a synthetic peptide that is identical to the 24-amino acid segment at the N-terminal of adrenocorticotropic hormone. It is intended for use as a diagnostic agent in the screening of patients presumed to have adrenocortical insufficiency. Cosyntropin may bind to sites located on the adrenergic nerve endings associated with the cardiac tissue, and such binding would interfere with the neuronal reuptake of the catecholamines

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: Q01718
Gene ID: 4158.0
Gene Symbol: MC2R
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
CORTROSYN

Approved Use

Cortrosyn™ (cosyntropin) for Injection is intended for use as a diagnostic agent in the screening of patients presumed to have adrenocortical insufficiency. Because of its rapid effect on the adrenal cortex it may be utilized to perform a 30-minute test of adrenal function (plasma cortisol response) as an office or outpatient procedure, using only 2 venipunctures (seeDOSAGE AND ADMINISTRATION section). Severe hypofunction of the pituitary - adrenal axis is usually associated with subnormal plasma cortisol values but a low basal level is not per se evidence of adrenal insufficiency and does not suffice to make the diagnosis. Many patients with proven insufficiency will have normal basal levels and will develop signs of insufficiency only when stressed. For this reason a criterion which should be used in establishing the diagnosis is the failure to respond to adequate corticotropin stimulation. When presumptive adrenal insufficiency is diagnosed by a subnormal Cortrosyn™ test, further studies are indicated to determine if it is primary or secondary. Primary adrenal insufficiency (Addison's disease) is the result of an intrinsic disease process, such as tuberculosis within the gland. The production of adrenocortical hormones is deficient despite high ACTH levels (feedback mechanism). Secondary or relative insufficiency arises as the result of defective production of ACTH leading in turn to disuse atrophy of the adrenal cortex. It is commonly seen, for example, as result of corticosteroid therapy, Sheehan's syndrome and pituitary tumors or ablation. The differentiation of both types is based on the premise that a primarily defective gland cannot be stimulated by ACTH whereas a secondarily defective gland is potentially functional and will respond to adequate stimulation with ACTH. Patients selected for further study as the result of a subnormal Cortrosyn™ test should be given a 3 or 4 day course of treatment with Repository Corticotropin Injection USP and then retested. Suggested doses are 40 USP units twice daily for 4 days or 60 USP units twice daily for 3 days. Under these conditions little or no increase in plasma cortisol levels will be seen in Addison's disease whereas higher or even normal levels will be seen in cases with secondary adrenal insufficiency.

Launch Date

1970
PubMed

PubMed

TitleDatePubMed
Adrenocorticotropin binding sites in rat cardiac tissue.
1990 Jan
Stress-related gene expression in brain and adrenal gland of porcine fetuses and neonates.
2005 Mar 1
Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide.
2018 Apr

Sample Use Guides

Cortrosyn™ (cosyntropin) for Injection may be administered intramuscularly or as a direct intravenous injection when used as a rapid screening test of adrenal function. It may also be given as an intravenous infusion over a 4 to 8 hour period to provide a greater stimulus to the adrenal glands. Doses of Cortrosyn™ 0.25 to 0.75 mg have been used in clinical studies and a maximal response noted with the smallest dose.
Route of Administration: Other
Substance Class Protein
Created
by admin
on Sat Dec 16 15:41:10 GMT 2023
Edited
by admin
on Sat Dec 16 15:41:10 GMT 2023
Protein Type HORMONE
Protein Sub Type
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
H86HJ92K8Y
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
COSYNTROPIN HEXAACETATE
MI  
Common Name English
TETRACOSACTIDE ACETATE [JAN]
Common Name English
TETRACOSACTIDE HEXAACETATE
Common Name English
COSYNTROPIN HEXAACETATE [MI]
Common Name English
COSYNTROPIN ACETATE
Common Name English
.ALPHA.1-24-CORTICOTROPIN, HEXAACETATE (SALT)
Common Name English
TETRACOSACTIDE ACETATE
JAN   WHO-DD  
Common Name English
Tetracosactide acetate [WHO-DD]
Common Name English
TETRACOSACTIDE HEXACETATE
Common Name English
COSYNTROPIN ACETATE [USP-RS]
Common Name English
SYNACTHEN
Brand Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 378212
Created by admin on Sat Dec 16 15:41:10 GMT 2023 , Edited by admin on Sat Dec 16 15:41:10 GMT 2023
Code System Code Type Description
ECHA (EC/EINECS)
245-145-2
Created by admin on Sat Dec 16 15:41:10 GMT 2023 , Edited by admin on Sat Dec 16 15:41:10 GMT 2023
PRIMARY
PUBCHEM
56841808
Created by admin on Sat Dec 16 15:41:10 GMT 2023 , Edited by admin on Sat Dec 16 15:41:10 GMT 2023
PRIMARY
FDA UNII
H86HJ92K8Y
Created by admin on Sat Dec 16 15:41:10 GMT 2023 , Edited by admin on Sat Dec 16 15:41:10 GMT 2023
PRIMARY
DRUG BANK
DBSALT001959
Created by admin on Sat Dec 16 15:41:10 GMT 2023 , Edited by admin on Sat Dec 16 15:41:10 GMT 2023
PRIMARY
SMS_ID
100000128571
Created by admin on Sat Dec 16 15:41:10 GMT 2023 , Edited by admin on Sat Dec 16 15:41:10 GMT 2023
PRIMARY
EVMPD
SUB15501MIG
Created by admin on Sat Dec 16 15:41:10 GMT 2023 , Edited by admin on Sat Dec 16 15:41:10 GMT 2023
PRIMARY
EVMPD
SUB35804
Created by admin on Sat Dec 16 15:41:10 GMT 2023 , Edited by admin on Sat Dec 16 15:41:10 GMT 2023
PRIMARY
MERCK INDEX
m3809
Created by admin on Sat Dec 16 15:41:10 GMT 2023 , Edited by admin on Sat Dec 16 15:41:10 GMT 2023
PRIMARY Merck Index
EPA CompTox
DTXSID90177179
Created by admin on Sat Dec 16 15:41:10 GMT 2023 , Edited by admin on Sat Dec 16 15:41:10 GMT 2023
PRIMARY
RS_ITEM_NUM
1150115
Created by admin on Sat Dec 16 15:41:10 GMT 2023 , Edited by admin on Sat Dec 16 15:41:10 GMT 2023
PRIMARY
ChEMBL
CHEMBL2103784
Created by admin on Sat Dec 16 15:41:10 GMT 2023 , Edited by admin on Sat Dec 16 15:41:10 GMT 2023
PRIMARY
CAS
60189-34-6
Created by admin on Sat Dec 16 15:41:10 GMT 2023 , Edited by admin on Sat Dec 16 15:41:10 GMT 2023
NON-SPECIFIC STOICHIOMETRY
CAS
22633-88-1
Created by admin on Sat Dec 16 15:41:10 GMT 2023 , Edited by admin on Sat Dec 16 15:41:10 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL